136 related articles for article (PubMed ID: 18094552)
21. Acquired biclonal chromosome X aberrations without autosomal chromosomal anomalies in acute myeloid leukemia.
Zeidan A; Phatak P
Cancer Genet Cytogenet; 2008 Mar; 181(2):125-30. PubMed ID: 18295665
[TBL] [Abstract][Full Text] [Related]
22. Unbalanced 1;7 translocation and therapy-induced hematologic disorders: a possible relationship.
Morrison-DeLap SJ; Kuffel DG; Dewald GW; Letendre L
Am J Hematol; 1986 Jan; 21(1):39-47. PubMed ID: 3706288
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
Johansson B; Mertens F; Mitelman F
Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
[TBL] [Abstract][Full Text] [Related]
24. Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms.
Knuutila S; Teerenhovi L; Larramendy ML; Elonen E; Franssila KO; Nylund SJ; Timonen T; Heinonen K; Mahlamäki E; Winqvist R
Genes Chromosomes Cancer; 1994 Jun; 10(2):95-102. PubMed ID: 7520272
[TBL] [Abstract][Full Text] [Related]
25. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. The Czechoslovak MDS Cooperative Group.
Michalová K; Musilová J; Zemanová Z
Czech Med; 1990; 13(4):133-44. PubMed ID: 2081440
[TBL] [Abstract][Full Text] [Related]
27. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications.
Dabaja BS; Faderl S; Thomas D; Cortes J; O'Brien S; Nasr F; Pierce S; Hayes K; Glassman A; Keating M; Kantarjian HM
Leukemia; 1999 Jun; 13(6):869-72. PubMed ID: 10360374
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
29. [Laboratory features of acute myelogenous leukemia in elderly patients].
Mori M
Rinsho Byori; 2001 May; 49(5):433-7. PubMed ID: 11402560
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic analysis in 941 consecutive patients with haematologic disorders.
Billström R; Nilsson PG; Mitelman F
Scand J Haematol; 1986 Jul; 37(1):29-40. PubMed ID: 3464085
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia.
Brozek I; Babińska M; Kardaś I; Woźniak A; Balcerska A; Hellmann A; Limon J
J Appl Genet; 2003; 44(3):401-12. PubMed ID: 12923315
[TBL] [Abstract][Full Text] [Related]
32. Normal cytogenetic values for bone marrow based on studies of bone marrow transplant donors.
Kuffel DG; Schultz CG; Ash RC; Dewald GW
Cancer Genet Cytogenet; 1991 Aug; 55(1):39-48. PubMed ID: 1913606
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of the del(20q) chromosome in hematologic disorders.
Aatola M; Armstrong E; Teerenhovi L; Borgström GH
Cancer Genet Cytogenet; 1992 Aug; 62(1):75-80. PubMed ID: 1521239
[TBL] [Abstract][Full Text] [Related]
34. Major karyotype aberrations, including t(3;12), in a patient with myelodysplastic syndrome.
Clare N; Hunke M; Manhoff LJ
Cancer Genet Cytogenet; 1984 Nov; 13(3):267-73. PubMed ID: 6498790
[TBL] [Abstract][Full Text] [Related]
35. Translocations involving chromosomes #3 and #12: hematologic diseases associated with abnormalities of these chromosomes.
Sandberg AA; Hecht BK; Ondreyco SM; Prieto F; Hecht F
Cancer Genet Cytogenet; 1982 Sep; 7(1):1-17. PubMed ID: 6754070
[TBL] [Abstract][Full Text] [Related]
36. Marrow chromosome studies in "preleukemia". Further correlation with clinical course.
Nowell PC
Cancer; 1971 Aug; 28(2):513-8. PubMed ID: 5566368
[No Abstract] [Full Text] [Related]
37. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
[TBL] [Abstract][Full Text] [Related]
38. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
[TBL] [Abstract][Full Text] [Related]
39. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
40. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
